Callum D Owen

3PUBLICATIONS
17CO-AUTHORS
Proteins and peptidesMedical infection agents (incl. prions)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jan 20, 2026
Structure-Guided Design of Potent and Selective Covalent Inhibitors Targeting the SARS-CoV-2 Papain-like Protease.

Mona Sharafi, Wei Pin Teh, Jeremy Green

|Dec 16, 2024
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses.

Malaika D Argade, Jazmin Galván Achi, Ryan Bott

|Jan 04, 2024
A stapled lipopeptide platform for preventing and treating highly pathogenic viruses of pandemic potential.

Gregory H Bird, J J Patten, William Zavadoski

Pageof 1

Frequent Collaborators

3 joint publications

Robert A Davey

2 joint publications

Kimberly M Morsheimer

1 joint publications

J J Patten

1 joint publications

Donna S Neuberg

1 joint publications

Richard A Bowen

1 joint publications

Loren D Walensky

1 joint publications

Malaika D Argade

1 joint publications

Jazmin Galván Achi

1 joint publications

Terry W Moore

1 joint publications

Michael Cameron

Frequent Collaborators

3 joint publications

Robert A Davey

2 joint publications

Kimberly M Morsheimer

1 joint publications

J J Patten

1 joint publications

Donna S Neuberg

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on : Sep 26, 2025

1.5K
High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
10:16

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

Published on : Oct 30, 2021

3.6K
Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on : Jan 15, 2020

8.3K
See more related videos

Top Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on : Sep 26, 2025

1.5K
High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
10:16

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

Published on : Oct 30, 2021

3.6K
Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on : Jan 15, 2020

8.3K
See more related videos